Search
Now showing items 1-10 of 12
Clinical presentation of desmoid tumors
(Springer, 2012)
Desmoid tumors (DT) constitute a rare fibroblastic proliferative disease. They present sporadically or as a manifestation of a hereditary syndrome such as Familial Adenomatous Polyposis (FAP). Despite the absence of ...
Clinical activity and tolerability of a 14-day infusional ifosfamide schedule in soft-tissue sarcoma
(2013)
Background. Soft-tissue sarcomas (STS) are a heterogeneous group of diseases with lack of effective treatments in most cases. Previous data suggest that continuous infusional ifosfamide regimens might improve cytotoxicity ...
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
(2009)
Background: Aggressive fibromatosis (AF) or desmoid tumour is a monoclonal proliferation which is locally invasive but does not metastasize. If local treatment fails to control the disease, systemic treatment with ...
Advanced aggressive fibromatosis: Effective palliation with chemotherapy
(2011)
Background. Aggressive fibromatosis (AF) is a locally invasive proliferative disease. The mainstay of treatment is surgery. Chemotherapy may be considered in inoperable AF following failure of hormonal therapy and/or NSAIDs. ...
Role of palliative chemotherapy in advanced epithelioid sarcoma
(2012)
Background: Epithelioid sarcoma is a rare soft tissue sarcoma subtype. The response of this disease to chemotherapy is not well described. The aim of this study was to investigate the response rate and progression-free ...
Chemotherapy in clear cell sarcoma
(2011)
Clear cell sarcoma is a rare translocation-related sarcoma. There have been few studies documenting the response rate and progression-free survival in clear cell sarcoma patients treated with palliative chemotherapy. The ...
Desmoid Tumour: clinical presentations.
(Springer Science, 2010)